Translating Orthogonal Biology Into Cutting-Edge Biotech Companies
Khanda is a biotech company builder. We create companies that advance orthogonal biology-based approaches and shape the development of much needed medicines.
A New Model for Biotech Company Creation
Across therapeutic areas, today’s drug development keeps circling familiar ground, targeting one pathway at a time, leaving unmet needs for patients who have few viable paths forward.
Khanda translates validated and emerging biological insights into biotech companies, each designed to unite orthogonal pathways with rigor and precision and deliver new standards in therapeutic efficacy. Our agile model lets us pursue potentially best-in-disease combinations accelerating new treatment options for patients around the world.
Our vision is a future where biological insight reliably becomes transformative therapy, changing the course of chronic disease and relieving its burden on patients.
Deep Expertise. Disciplined Execution.
Khanda brings together a team of experienced drug developers, scientists, and company builders united by a shared commitment to disciplined speed and meaningful patient impact.
